Pharmacokinetics and safety of eptinezumab in children and adolescents with migraine
The PK profile in children and adolescents was consistent across different dose levels and weight groups. These results support the use of weight-based eptinezumab dosing in children and adolescents with migraine. Eptinezumab was generally well tolerated, with no new safety signals observed in this population relative to those observed in adults.
Authors
- Annika Lindstén
- Andrew D. Hershey (ORCID: https://orcid.org/0000-0002-1598-7536)
- Monika Rosén (ORCID: https://orcid.org/0000-0002-2815-8294)
- Johan Areberg (ORCID: https://orcid.org/0000-0001-9767-9643)
- Line Pickering (ORCID: https://orcid.org/0000-0002-3062-8881)
Institutions
- Cincinnati Children's Hospital Medical Center (US)
- Lundbeck (Denmark) (DK)
- University of Cincinnati Medical Center (US)
Publication Details
- Journal
- Headache The Journal of Head and Face Pain
- Published
- 2025-05-30
- DOI
- https://doi.org/10.1111/head.14959
- Citations
- 1
- Primary Topic
- Migraine and Headache Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.47
Funders
- H. Lundbeck A/S